Skip to content

Clinical research on the early intervention of chronic coronary syndrome (CCS) population in extreme weather with Quick-Acting Heart-Saving Pills

Clinical research on the early intervention of chronic coronary syndrome (CCS) population in extreme weather with Quick-Acting Heart-Saving Pills

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001497
Enrollment
Unknown
Registered
2025-07-26
Start date
2025-07-28
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic coronary syndrome

Interventions

Sponsors

Tianjin Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for chronic coronary syndrome (CCS); 2. It meets the diagnostic criteria for blood stasis syndrome of angina pectoris in coronary heart disease; 3. Gender and disease duration are not limited. Age should be between 18 and 80 years old.

Exclusion criteria

Exclusion criteria: Patients with severe symptoms of coronary heart disease but poor control effects such as those diagnosed with heart failure cardiomyopathy myocarditis severe metabolic diseases malignant tumors severe liver failure or renal failure etc. 2. Patients with cognitive dysfunction or diagnosed with mental illness; 3. Patients with allergic constitutions or those who are clearly allergic to the therapeutic drugs in this study; 4. Patients with poor compliance or those who will not be able to attend the visit as planned; 5. The researcher believes that there are possible circumstances other than those mentioned above that make participation in this trial inappropriate.

Design outcomes

Primary

MeasureTime frame
The incidence of major adverse cardiovascular and cerebrovascular events (MACCE);

Secondary

MeasureTime frame
Stress Assessment Scale;Evaluation of therapeutic effects on blood stasis syndrome;Evaluation of the therapeutic effect of symptoms and signs;Seattle Angina Survey Scale;Visual Analogue Scale (VAS) score for Chest pain;Somatic Symptom Scale;Evaluation of the therapeutic effect of angina pectoris;European Five-Dimensional Health Scale;Cardiac function classification assessment;

Countries

China

Contacts

Public ContactLi Chun Jie

Tianjin Chest Hospital

Lichunjie0227@126.com13820600988

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026